Professor David Miller is Professor of Neurology at UCL. He is a clinical neurologist and runs a large tertiary referral service for neuro-inflammatory disorders. His work on brain imaging applied to multiple sclerosis has been of fundamental importance in understanding the sequence of events in MS relapses. He provided key evidence for the effectiveness of disease modifying treatments through monthly MRI scanning with gadolinium chelates to detect active lesions. He led the proof-of-concept trials of natalizumab, an anti-adhesion molecule antibody that is now widely used to treat very active relapsing remitting MS.
Fellow
Back to directory listingProfessor David Miller FMedSci
Job Title
Emeritus Professor of Clinical Neurology
Department
Department of Neuroinflammation
Institution
University College London (UCL)
Year elected
2010
Interests
SpecialitiesMultiple Sclerosis, neuroimaging, MRI, clinical trials and experimental therapeutics
Section committee elected byNeuroscience (including neurology and neurosurgery), physiology, pharmacological sciences